Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AfyaBSP:A2FY34 +3.05%69 Receivables Turnover is 1.22 as of Jun. 2026. GuruFocus rates BSP:A2FY34 with a GF Score™ of 69/100 and a GF Value™ of R$53.69 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 248 Education companies, Afya ranks worse than 70.16% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Afya's Revenue for the
three
months ended in Jun. 2026 was R$972 Mil. Afya's average Accounts Receivable for the
three
months ended in Jun. 2026 was R$799 Mil.
Hence, Afya's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.22.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Afya Receivables Turnover Related Terms
Afya Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Afya's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:A2FY34 vs LINC, PXED, COUR: Receivables Turnover Comparison
For the Education & Training Services subindustry, Afya's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afya Receivables Turnover vs Education Industry
For the Education industry and Consumer Defensive sector, Afya's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Afya's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afya (BSP:A2FY34) has a Receivables Turnover of 1.22 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Afya and its competitors. According to the industry distribution chart, Afya ranks #174 out of 248 companies in the Education industry, placing it in the top 70.2%.
Is Afya's Receivables Turnover too high?
Afya's current Receivables Turnover is 1.22. The Education industry median Receivables Turnover is 11.00. Afya's value of 1.22 is 88.9% below this industry median. Based on the distribution chart, Afya ranks #174 out of 248 companies in the Education industry, which is below the industry midpoint. Overall, Afya has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Afya's Receivables Turnover compare to LINC and PXED?
According to the Education industry distribution chart, Afya ranks #174 out of 248 companies for Receivables Turnover. This places Afya in the lower half of its industry. The industry median Receivables Turnover is 11.00. Afya's value of 1.22 is 88.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Education company?
The median Receivables Turnover among Education companies is 11.00, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afya's current Receivables Turnover of 1.22 is 88.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Afya and its competitors. For the Education industry, the median Receivables Turnover is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afya's current Receivables Turnover is 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afya stock overvalued right now?
Based on GuruFocus' analysis, Afya (BSP:A2FY34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$53.69, compared to a current price of R$36.12 — trading 32.7% below its estimated fair value. The current Receivables Turnover is 1.22 and 88.9% below the Education industry median of 11.00. Afya's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Afya (BSP:A2FY34), the current Receivables Turnover is 1.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afya (BSP:A2FY34) Overvalued in 2026?
Based on GuruFocus' analysis, Afya stock appears to be undervalued.
The current stock price of R$36.12 is trading 32.7% below its estimated GF Value™ of R$53.69.
GuruFocus considers Afya to be Significantly Undervalued.
Key valuation signals for BSP:A2FY34:
Receivables Turnover: 1.22
GF Value™: R$53.69 vs. price of R$36.12 (32.7% below fair value)
Industry Position: 88.9% below the Education median (#174 of 248)
No single metric tells the full story. See the BSP:A2FY34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
69GF Score
Get the complete analysis for BSP:A2FY34
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:A2FY34 has been successfully added to your 
